Pulse Biosciences, Inc. Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation
Pulse Biosciences, Inc. (PLSE) reported Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation of -$613.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation · last filed 2022-03-31
- Pulse Biosciences, Inc. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2019 was -$613.00K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 12 month |
|---|---|
| 2019-12-31 | -$613.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |